TheraPsil

Psyched: DMT & SSRIs For Depression, MDMA Training, Negative Responses To Psychedelics & More

Canadian Practitioners Can Now Enroll In MDMA-Assisted Psychotherapy Training Program

Canadian Psychedelics Company And Nonprofit Team Up To Accelerate Access And Product Launch

Canadian Practitioners Can Now Enroll In MDMA-Assisted Psychotherapy Training Program

Canadian Psychedelics Company And Nonprofit Team Up To Accelerate Access And Product Launch

Canada's Ongoing Struggle For Access To Natural Psilocybin As A Therapeutic Nabs Business Support

Canada-Based Project Solace Aims To Provide Access And Data On Medical Psilocybin

Canada's Ongoing Struggle For Access To Natural Psilocybin As A Therapeutic Nabs Business Support

Canada-Based Project Solace Aims To Provide Access And Data On Medical Psilocybin

Psyched: Cybin Debuts On NYSE, Nonprofits In Psychedelics Space Reach New Milestones, Filament Receives Psilocybin Patent

2020 Was The Year of Psychedelics — Here's Why

TheraPsil Recent News

Psyched: German Government Funds Psilocybin Study, Field Trip Opens Psilocybin Clinic

Global Developments in Germany, Canada and Brazil Germany has approved a large phase 2b study on psilocybin for treatment-resistant depression.

'Psyched': Canada Makes Psilocybin History, Usona Publishes New Method for Psilocybin Synthesis

Canadian Government Allows Psilocybin Treatment to 4 Terminally-Ill Patients In a landmark decision, the Canadian Minister of Health Patty Hajdu allowed four terminally-ill cancer patients to legally use psilocybin as part of a palliative care treatment for end-of-life distress.